At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 212 enrolled
Drug / intervention
IDP-118 Lotion +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
In Brief
A Phase 2 clinical trial evaluating IDP-118 Lotion, IDP-118 Monad HP Lotion, and 2 other interventions for Plaque Psoriasis. Completed, enrolled 212 participants across 18 sites.
Detailed Summary
The objective of the study is to evaluate the safety and efficacy of a topical lotion
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPlaque Psoriasis
CountriesUnited States
CollaboratorsDow Pharmaceutical Sciences
Timeline
Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJan 2014
Enrollment StartFeb 2014
Primary CompletionNov 2014
TodayJul 2026
First PostedJan 24, 2014
Enrollment StartFeb 1, 2014
Primary CompletionNov 1, 2014
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 12.4 years ago
Interventions
IDP-118 Lotiondrug
Lotion
IDP-118 Monad HP Lotiondrug
Active Comparator
IDP-118 Monad Taz Lotiondrug
Active Comparator
IDP-118 Vehicle Lotiondrug
Vehicle